Jenny Lester

6.5k total citations
26 papers, 868 citations indexed

About

Jenny Lester is a scholar working on Reproductive Medicine, Oncology and Cancer Research. According to data from OpenAlex, Jenny Lester has authored 26 papers receiving a total of 868 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Reproductive Medicine, 8 papers in Oncology and 8 papers in Cancer Research. Recurrent topics in Jenny Lester's work include Ovarian cancer diagnosis and treatment (15 papers), Endometrial and Cervical Cancer Treatments (6 papers) and Cancer-related molecular mechanisms research (6 papers). Jenny Lester is often cited by papers focused on Ovarian cancer diagnosis and treatment (15 papers), Endometrial and Cervical Cancer Treatments (6 papers) and Cancer-related molecular mechanisms research (6 papers). Jenny Lester collaborates with scholars based in United States, Israel and Georgia. Jenny Lester's co-authors include Beth Y. Karlan, Sandra Oršulić, Ann E. Walts, Judy Dering, Dong‐Joo Cheon, Jessica A. Beach, Dror Berel, Christine Walsh, Xiaojiang Cui and Yunguang Tong and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cancer Research.

In The Last Decade

Jenny Lester

26 papers receiving 854 citations

Peers

Jenny Lester

ONCOL

GENET

Karen H. Lu United States

Arisa Ueki Japan

Andrew Berchuck United States

Yasuhisa Terao Japan

Hyun S. Shvartsman United States

Mark E. Borowsky United States

Adriaan Vanderstichele Belgium

Andrew N. Stephens Australia

Barbara M. Buttin United States

Katherine C. Kurnit United States

Karen H. Lu United States

Jenny Lester

344 ×1.0

447 ×1.3

261 ×1.1

ONCOL

290 ×1.2

137 ×1.0

GENET

Citations per year, relative to Jenny Lester Jenny Lester (= 1×) peers Karen H. Lu

Countries citing papers authored by Jenny Lester

Since Specialization

Citations

This map shows the geographic impact of Jenny Lester's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jenny Lester with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jenny Lester more than expected).

Fields of papers citing papers by Jenny Lester

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jenny Lester. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jenny Lester. The network helps show where Jenny Lester may publish in the future.

Co-authorship network of co-authors of Jenny Lester

This figure shows the co-authorship network connecting the top 25 collaborators of Jenny Lester. A scholar is included among the top collaborators of Jenny Lester based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jenny Lester. Jenny Lester is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hu, Ye, Barbie Taylor‐Harding, Yael Raz, et al.. (2020). Are Epithelial Ovarian Cancers of the Mesenchymal Subtype Actually Intraperitoneal Metastases to the Ovary?. Frontiers in Cell and Developmental Biology. 8. 647–647. 13 indexed citations

Hooda, Jagmohan, Marián Novak, Matthew P. Salomon, et al.. (2018). Early Loss of Histone H2B Monoubiquitylation Alters Chromatin Accessibility and Activates Key Immune Pathways That Facilitate Progression of Ovarian Cancer. Cancer Research. 79(4). 760–772. 40 indexed citations

Saini, Uksha, Adrian A. Suarez, Shan K. Naidu, et al.. (2018). STAT3/PIAS3 Levels Serve as “Early Signature” Genes in the Development of High-Grade Serous Carcinoma from the Fallopian Tube. Cancer Research. 78(7). 1739–1750. 17 indexed citations

Lester, Jenny, Christine Walsh, Ilana Cass, et al.. (2018). Language as a barrier to cancer clinical trial accrual: assessing consenting team knowledge and practices for cancer clinical trial consent among low English fluency patients. SHILAP Revista de lepidopterología. 38(1). 23 indexed citations

Prendergast, Emily, Felipe Segato Dezem, Jenny Lester, et al.. (2018). Optimizing exosomal RNA isolation for RNA-Seq analyses of archival sera specimens. PLoS ONE. 13(5). e0196913–e0196913. 39 indexed citations

Zakhour, Mae, Jenny Lester, B.J. Rimel, et al.. (2016). Occult and subsequent cancer incidence following risk-reducing surgery in BRCA mutation carriers. Gynecologic Oncology. 143(2). 231–235. 62 indexed citations

Dao, Fanny, Brooke A. Schlappe, Jill Tseng, et al.. (2016). Characteristics of 10-year survivors of high-grade serous ovarian carcinoma. Gynecologic Oncology. 141(2). 260–263. 78 indexed citations

Liang, Margaret, Hyuk‐Jae Chang, Jenny Lester, et al.. (2016). Glasgow Prognostic Score Associated with Lower Rates of R0 Cytoreduction in Women with Stage III Serous Ovarian Cancer. Gynecologic Oncology. 143(1). 219–219. 2 indexed citations

Rimel, B.J., Jenny Lester, Leah Sabacan, et al.. (2015). A novel clinical trial recruitment strategy for women's cancer. Gynecologic Oncology. 138(2). 445–448. 10 indexed citations

10.

Cheon, Dong‐Joo, Andrew J. Li, Jessica A. Beach, et al.. (2015). ADAM12 is a prognostic factor associated with an aggressive molecular subtype of high-grade serous ovarian carcinoma. Carcinogenesis. 36(7). 739–747. 21 indexed citations

11.

Novak, Marián, Jenny Lester, Alison M. Karst, et al.. (2015). Stathmin 1 and p16INK4A are sensitive adjunct biomarkers for serous tubal intraepithelial carcinoma. Gynecologic Oncology. 139(1). 104–111. 44 indexed citations

12.

Cass, Ilana, Ann E. Walts, Denise Barbuto, Jenny Lester, & Beth Y. Karlan. (2014). A cautious view of putative precursors of serous carcinomas in the fallopian tubes of BRCA mutation carriers. Gynecologic Oncology. 134(3). 492–497. 19 indexed citations

13.

Cheon, Dong‐Joo, Ann E. Walts, Jessica A. Beach, et al.. (2014). Differential expression of argininosuccinate synthetase in serous and non‐serous ovarian carcinomas. The Journal of Pathology Clinical Research. 1(1). 41–53. 17 indexed citations

14.

Rimel, B.J., et al.. (2014). A novel clinical trial recruitment strategy for women's cancers. Gynecologic Oncology. 133. 142–143. 1 indexed citations

15.

Cheon, Dong‐Joo, Ann E. Walts, Jessica A. Beach, et al.. (2014). Differential expression of ASS1 in serous and non-serous ovarian carcinomas. n/a–n/a. 2 indexed citations

16.

Cheon, Dong‐Joo, Yunguang Tong, Myung‐Shin Sim, et al.. (2013). A Collagen-Remodeling Gene Signature Regulated by TGF-β Signaling Is Associated with Metastasis and Poor Survival in Serous Ovarian Cancer. Clinical Cancer Research. 20(3). 711–723. 265 indexed citations

17.

Powell, C. Bethan, Elizabeth M. Swisher, Ilana Cass, et al.. (2013). Long term follow up of BRCA1 and BRCA2 mutation carriers with unsuspected neoplasia identified at risk reducing salpingo-oophorectomy. Gynecologic Oncology. 129(2). 364–371. 65 indexed citations

18.

Karlan, Beth Y., Judy Dering, Christine Walsh, et al.. (2013). POSTN/TGFBI-associated stromal signature predicts poor prognosis in serous epithelial ovarian cancer. Gynecologic Oncology. 132(2). 334–342. 75 indexed citations

19.

Wenzel, Lari, et al.. (2012). Biopsychological Stress Factors in BRCA Mutation Carriers. Psychosomatics. 53(6). 582–590. 15 indexed citations

20.

Lester, Jenny. (2005). Wyburn-Mason Syndrome. Journal of Neuroimaging. 15(3). 284–285. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact